Sze Wai Tsang

Lehman Brothers Holdings, Inc. engages in the provision of securities underwriting and investment services. The company is headquartered in New York, NY.

Templeton Asset Management Ltd. (Hong Kong) (TAML-HK) is the Hong Kong-based asset management division of Templeton Asset Management Ltd., ultimately held by Franklin Resources, Inc. (NYSE: BEN) in the US. The firm originated as a Hong Kong research office in 1987, and has been supported since 1994 by a marketing office (Franklin Templeton Investments Asia Ltd.) which distributes a range of unit trusts from the Franklin and Templeton families of funds. TAML-HK performs research and advises the parent company on the management of Templeton sub-funds invested in Asia and the Far East. The investment teams in Hong Kong and Singapore work in close relationship. The firm is headquartered in Hong Kong.

Templeton Asset Management Ltd. (TAML) is a mutual fund management firm headquartered in Singapore. The firm was founded in 1992 and is a wholly owned subsidiary of Franklin Templeton Capital Holdings Pte. Ltd., ultimately owned by Franklin Resources, Inc. (NYSE: BEN) in the US. TAML provides investment advisory and portfolio management services to US Registered Funds and Non-US Registered Funds, as well as Private Funds and Separate Accounts.

Real Nutriceutical Group Ltd. operates as an investment holding company, which engages in the manufacture and sale of health & nutritional supplements and pharmaceutical products. It operates through the following segments: Health and Nutritional Supplements segment, Health Drinks and Pharmaceutical Products segment. The Health and Nutritional Supplements segment is engaged in the manufacture and sales of health and nutritional supplements. Its products include amino acids products, nutrient products and imported products. The Health Drinks segment is engaged in the manufacture and sales of health drinks. Its products include herbal tea products and amino acid drinks. The Pharmaceutical Products segment is engaged in the manufacture and sales of pharmaceutical products. Its main products include eye drops and antineoplastic drugs. The company was founded by Fu Cai Wang in 1997 and is headquartered in Hong Kong.